Identification and Comprehensive Co-Detection of Necrotic and Viable Aneuploid Cancer Cells in Peripheral Blood.
MRD
SE-iFISH
liquid biopsy
necrotic CTCs and CTECs
rapid evaluation of therapeutic effects
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
12 Oct 2021
12 Oct 2021
Historique:
received:
10
09
2021
revised:
07
10
2021
accepted:
09
10
2021
entrez:
23
10
2021
pubmed:
24
10
2021
medline:
24
10
2021
Statut:
epublish
Résumé
Aneuploid circulating tumor cells (CTCs, CD31
Identifiants
pubmed: 34680256
pii: cancers13205108
doi: 10.3390/cancers13205108
pmc: PMC8534250
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
N Engl J Med. 2004 Aug 19;351(8):781-91
pubmed: 15317891
Cancer Lett. 2018 Jan 1;412:99-107
pubmed: 29031565
Clin Transl Med. 2015 Dec;4(1):38
pubmed: 26718583
Nat Rev Cancer. 2005 Oct;5(10):773-85
pubmed: 16195750
Front Oncol. 2019 Mar 05;9:129
pubmed: 30891428
Proc Natl Acad Sci U S A. 2019 Jun 4;116(23):11390-11395
pubmed: 31085648
J Thorac Oncol. 2012 Feb;7(2):306-15
pubmed: 22173704
PLoS One. 2019 Apr 17;14(4):e0210706
pubmed: 30995247
Cancer Lett. 2021 Oct 1;517:78-87
pubmed: 34126192
J Cell Biol. 2011 Feb 7;192(3):373-82
pubmed: 21300848
Cancer Discov. 2017 May;7(5):462-477
pubmed: 28331002
Int J Mol Sci. 2018 Apr 24;19(5):
pubmed: 29695087
Cells. 2019 Sep 25;8(10):
pubmed: 31557946
Clin Cancer Res. 2000 Jul;6(7):2815-20
pubmed: 10914729
Nature. 2016 Aug 11;536(7615):215-8
pubmed: 27487218
Oncotarget. 2015 Sep 29;6(29):27049-64
pubmed: 26267323
Nat Rev Genet. 2020 Jan;21(1):44-62
pubmed: 31548659
Lab Invest. 2021 Mar;101(3):381-395
pubmed: 33483597
Nat Rev Genet. 2012 Jan 24;13(3):189-203
pubmed: 22269907
J Thorac Oncol. 2009 Jan;4(1):30-6
pubmed: 19096303
Oncotarget. 2014 Aug 30;5(16):6594-602
pubmed: 25026283
Sci Adv. 2019 Jun 19;5(6):eaav4275
pubmed: 31223646
Cancer Manag Res. 2021 Jun 01;13:4417-4431
pubmed: 34103996
Clin Transl Med. 2020 Jul;10(3):e128
pubmed: 32659050
Clin Cancer Res. 2018 Nov 1;24(21):5261-5271
pubmed: 30012565
Mol Neurodegener. 2009 Mar 25;4:15
pubmed: 19320978
Sci Rep. 2017 Aug 29;7(1):9789
pubmed: 28852197
Oncotarget. 2017 Jan 3;8(1):1884-1912
pubmed: 27683128
Semin Cancer Biol. 2020 Feb;60:334-343
pubmed: 31445220
Cancer Lett. 2020 Jan 28;469:355-366
pubmed: 31678168
Mol Oncol. 2021 Aug 28;:
pubmed: 34455700
Nat Med. 2015 Jul;21(7):663-5
pubmed: 26151324
Clin Cancer Res. 2008 Nov 1;14(21):7004-10
pubmed: 18980996
Br J Cancer. 2008 Nov 4;99(9):1375-9
pubmed: 18797460
Diagnostics (Basel). 2018 Apr 18;8(2):
pubmed: 29670052
Circ Res. 1977 Jul;41(1):2-8
pubmed: 324656
Cancer Res. 2005 Apr 1;65(7):2507-10
pubmed: 15805239
Nat Rev Clin Oncol. 2019 Jul;16(7):409-424
pubmed: 30796368
Nat Rev Mol Cell Biol. 2020 Jun;21(6):341-352
pubmed: 32300252
Oncotarget. 2017 Dec 21;9(2):2705-2714
pubmed: 29416803
Sci Rep. 2017 Jan 05;7:39975
pubmed: 28054593
Cytometry. 2001 Apr 1;43(4):290-6
pubmed: 11260596
Ther Adv Med Oncol. 2020 May 18;12:1758835920918470
pubmed: 32489429
Nat Rev Cancer. 2004 Jun;4(6):448-56
pubmed: 15170447
Oncotarget. 2015 Jun 20;6(17):15639-51
pubmed: 25909226
Nat Rev Clin Oncol. 2016 May;13(5):291-304
pubmed: 26598944
Cells. 2020 Jun 24;9(6):
pubmed: 32599893
Nat Rev Cancer. 2021 Feb;21(2):89-103
pubmed: 33432169